Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands: Implications for Immunotherapy

Immunity

Volumn 20, Issue 1, 2004, Pages 107-118

  Wang, Helen Y ^a   Lee, Dean A ^a   Peng, Guangyong ^a   Guo, Zhong ^a   Li, Yanchun ^a   Kiniwa, Yukiko ^a   Shevach, Ethan M ^b   Wang, Rong Fu ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR; LIGAND; MONOCLONAL ANTIBODY CD3; PROTEIN SUBUNIT; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CANCER INHIBITION; CANCER PATIENT; CELL ACTIVITY; CELL CLONE; CELL CONTACT; CELL LINE; CELL PROLIFERATION; CELL SEPARATION; CONTROLLED STUDY; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNOTHERAPY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; T LYMPHOCYTE; TUMOR CELL;

EID: 1642497640     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00359-5     Document Type: Article

References (45)

1. Apostolou I., Sarukhan A., Klein L., von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3:2002;756-763.
2. Chen Y.T., Scanlan M.J., Sahin U., Tureci O., Gure A.O., Tsang S., Williamson B., Stockert E., Pfreundschuh M., Old L.J. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA. 94:1997;1914-1918.
3. Curotto de Lafaille M.A., Lafaille J.J. CD4(+) regulatory T cells in autoimmunity and allergy. Curr. Opin. Immunol. 14:2002;771-778.
4. Dieckmann D., Bruett C.H., Ploettner H., Lutz M.B., Schuler G. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J. Exp. Med. 196:2002;247-253.
5. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells. Nat. Immunol. 4:2003;330-337.
6. Francois Bach J. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 3:2003;189-198.
7. Germain R.N. MHC-dependent antigen processing and peptide presentation. providing ligands for T lymphocyte activation Cell. 76:1994;287-299.
8. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., Roncarolo M.G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:1997;737-742.
9. Hori S., Haury M., Coutinho A., Demengeot J. Specificity requirements for selection and effector functions of CD25+CD4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA. 99:2002;8213-8218.
10. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor foxp3. Science. 299:2003;1057-1061.
11. Houghton A.N., Gold J.S., Blachere N.E. Immunity against cancer. lessons learned from melanoma Curr. Opin. Immunol. 13:2001;134-140.
12. Janssen E.M., Lemmens E.E., Wolfe T., Christen U., Von Herrath M.G., Schoenberger S.P. CD4(+) T cells are required for secondary expansion and memory in CD8(+) T lymphocytes. Nature. 421:2003;852-856.
13. Jonuleit H., Schmitt E., Kakirman H., Stassen M., Knop J., Enk A.H. Infectious tolerance. human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells J. Exp. Med. 196:2002;255-260.
14. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for Scurfin in CD4(+)CD25(+) T regulatory cells. Nat. Immunol. 4:2003;337-342.
15. Lethe B., Lucas S., Michaux L., De Smet C., Godelaine D., Serrano A., De Plaen E., Boon T. LAGE-1, a new gene with tumor specificity. Int. J. Cancer. 76:1998;903-908.
16. Levings M.K., Bacchetta R., Schulz U., Roncarolo M.G. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int. Arch. Allergy Immunol. 129:2002;263-276. a.
17. Levings M.K., Sangregorio R., Sartirana C., Moschin A.L., Battaglia M., Orban P.C., Roncarolo M.G. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 196:2002;1335-1346. b.
18. Liyanage U.K., Moore T.T., Joo H.G., Tanaka Y., Herrmann V., Doherty G., Drebin J.A., Strasberg S.M., Eberlein T.J., Goedegebuure P.S., Linehan D.C. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 169:2002;2756-2761.
19. Maloy K.J., Powrie F. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:2001;816-822.
20. Mandic M., Almunia C., Vicel S., Gillet D., Janjic B., Coval K., Maillere B., Kirkwood J.M., Zarour H.M. The alternative open reading frame of LAGE-1 gives rise to multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type tumor-reactive CD4+ T cells. Cancer Res. 63:2003;6506-6515.
21. McKee M.D., Clay T.M., Diamond R.A., Rosenberg S.A., Nishimura M.I. Quantitation of T-cell receptor frequencies by competitive polymerase chain reaction. dynamics of T-cell clonotype frequencies in an expanding tumor-infiltrating lymphocyte culture J. Immunother. 23:2000;419-429.
22. Powrie F., Maloy K.J. Immunology. Regulating the regulators. Science. 299:2003;1030-1031.
23. Roncarolo M.G., Levings M.K. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol. 12:2000;676-683.
24. Rosenberg S.A. Progress in human tumour immunology and immunotherapy. Nature. 411:2001;380-384.
25. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1995;1151-1164.
26. Sakaguchi S., Sakaguchi N., Shimizu J., Yamazaki S., Sakihama T., Itoh M., Kuniyasu Y., Nomura T., Toda M., Takahashi T. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells. their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance Immunol. Rev. 182:2001;18-32.
27. Shedlock D.J., Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science. 300:2003;337-339.
28. Shevach E.M. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18:2000;423-449.
29. Shevach E.M. CD4+ CD25+ suppressor T cells. more questions than answers Nat. Rev. Immunol. 2:2002;389-400.
30. Shimizu J., Yamazaki S., Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells. a common basis between tumor immunity and autoimmunity J. Immunol. 163:1999;5211-5218.
31. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:2002;135-142.
32. Slager E.H., Borghi M., van der Minne C.E., Aarnoudse C.A., Havenga M.J., Schrier P.I., Osanto S., Griffioen M. CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL. a tumor antigen translated in an alternative open reading frame J. Immunol. 170:2003;1490-1497.
33. Sun J.C., Bevan M.J. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science. 300:2003;339-342.
34. Sutmuller R.P., van Duivenvoorde L.M., van Elsas A., Schumacher T.N., Wildenberg M.E., Allison J.P., Toes R.E., Offringa R., Melief C.J. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med. 194:2001;823-832.
35. von Herrath M.G., Harrison L.C. Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol. 3:2003;223-232.
36. Wang R.-F. The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity. Trends Immunol. 22:2001;269-276.
37. Wang R.-F. Enhancing antitumor immune responses. intracellular peptide delivery and identification of MHC class II-restricted tumor antigens Immunol. Rev. 188:2002;65-80.
38. Wang R.-F., Johnston S.L., Zeng G., Schwartzentruber D.J., Rosenberg S.A. A breast and melanoma-shared tumor antigen. T cell responses to antigenic peptides translated from different open reading frames J. Immunol. 161:1998;3596-3606.
39. Wang R.-F., Wang X., Atwood A.C., Topalian S.L., Rosenberg S.A. Cloning genes encoding MHC class II-restricted antigens. mutated CDC27 as a tumor antigen Science. 284:1999;1351-1354. a.
40. Wang R.-F., Wang X., Rosenberg S.A. Identification of a novel MHC class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4+ T cells. J. Exp. Med. 189:1999;1659-1667. b.
41. Wang H.Y., Zhou J., Zhu K., Riker A.I., Marincola F.M., Wang R.-F. Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells. its role in extracellular matrix formation and tumor metastasis J. Exp. Med. 195:2002;1397-1406.
42. Weiner H.L. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol. Rev. 182:2001;207-214.
43. Woo E.Y., Chu C.S., Goletz T.J., Schlienger K., Yeh H., Coukos G., Rubin S.C., Kaiser L.R., June C.H. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 61:2001;4766-4772.
44. Woo E.Y., Yeh H., Chu C.S., Schlienger K., Carroll R.G., Riley J.L., Kaiser L.R., June C.H. Cutting edge. regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation J. Immunol. 168:2002;4272-4276.
45. Wood K.J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3:2003;199-210.